期刊文献+

NUMB表达对肝细胞癌患者预后的影响 被引量:4

Influence of NUMB Expression on Prognosis in Patients with Hepatocellular Carcinoma
下载PDF
导出
摘要 目的探讨NUMB在肝细胞癌(肝癌)中的表达及其与患者临床因素、预后的关系。方法根治性手术切除的肝癌病理标本119例,使用免疫组织化学(IHC)方法检测肝癌组织及癌旁组织中NUMB蛋白,并分析NUMB的表达与患者临床因素及预后的关系。结果肝癌组织中NUMB表达阳性率为36.1%(43/119),明显低于癌旁组织的100.0%(119/119)(P<0.01);NUMB表达缺失与肿瘤分化程度、脉管侵犯、早期复发及BCLC分期相关(P<0.05);NUMB表达缺失的患者,总体生存率及无瘤生存率均下降(P<0.01)。Cox多因素分析显示NUMB为影响肝癌患者预后的独立危险因素(P<0.01)。结论 NUMB在肝癌组织中表达缺失,并且其表达的缺失与肝癌侵袭特性有关,为影响患者预后的独立危险因素。 Objective To investigate NUMB expression in hepatocellular carcinoma(HCC) patients as well as its correlation with HCC patients’clinicopathological characteristics and prognosis.Methods Clinical samples were obtained from 119 HCC patients who had undergone curative liver resection.Immunohistochemistry assay was used to detect NUMB protein in HCC tissues and adjacent non-tumor tissues.The correlation of NUMB expression with clinicopathological characteristics and prognosis was analyzed.Results The positive rate of NUMB expression in HCC tissues was 36.1%(43 /119),which was significantly lower than that in adjacent tissues [100%(119 /119),P〈0.01];Deficiency of NUMB expression was associated with worse tumor differentiation,vascular invasion,early recurrence and advanced BCLC stage(P〈0.05);HCC patients with deficiency of NUMB expression had shorter overall survival and recurrence-free survival(P〈0.01).Cox multivariate analyses showed that NUMB was an independent risk factor of HCC patients’prognosis(P〈0.01).Conclusion NUMB expression is markedly down-regulated in HCC tissues.Deficiency of NUMB expression correlates with the characteristics of invasion in HCC.NUMB is an independent risk factor of prognosis in HCC.
出处 《广西医学》 CAS 2013年第7期813-815,823,共4页 Guangxi Medical Journal
基金 国家自然科学基金(81201634)
关键词 肝细胞癌 NUMB 临床病理因素 侵袭 预后 Hepatocellular carcinoma NUMB Clinicopathological Characteristics Invasion Prognosis
  • 相关文献

参考文献11

  • 1Hang J, Hu K, Yuan Y, et al. CHK1 targets spleen tyrosine kinase(L) for proteolysis in hepatocellular carcinoma[ J]. J Clin Invest,2012,122 (6) : 2 165 - 2 175.
  • 2Katoh M, Katoh M. NUMB is a break of WNT-Notch signa- ling cycle[J]. Int J Mol Med,2006,18(3) :517 -521.
  • 3Guruharsha KG, Kankel MW, Artavanis-Tsakonas S. The Notch signalling system:recent insights into the complexity of a conserved pathway [ J ]. Nature reviews Genetics, 2012, 13(9) :654-666.
  • 4Jiang X, Xing H, Kim TM, et al. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor reeeptor and Skpl-Cullin-F-box ubiquitin ligase activity [J]. Stem cells,2012,30(7):1 313 -1 326.
  • 5Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi [ J ]. Nature, 2010,466 (7 307) :765 - 768.
  • 6Rennstam K, McMichael N, Berglund P, et al. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer [ J ]. Breast Cancer Res Treat,2010,122 (2) : 315 - 324.
  • 7Wu J, Du J, Liu L,et al. Elevated pretherapy serum ILl7 in primary hepatocellular carcinoma patients correlate to in- creased risk of early recurrence after curative hepatectomy [ J ]. PLoS One,2012,7 (12) : e50035.
  • 8Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clini ,2011,61 (2) :69 - 90.
  • 9Song Y, Lu B. Interaction of Notch signaling modulator Numb with alpha-Adaptin regulates endocytosis of Notch pathway components and cell fate determination of neural stem cells[ J]. J Biol Chem,2012,287 (21) : 17 716 - 17 728.
  • 10Moellering RE, Comejo M, Davis TN, et al. Direct inhibition of the NOTCH transcription factor complex [ J ]. Nature, 2009,462 (7 270) : 182 - 188.

同被引文献29

  • 1Melchiorre Cervello,Giuseppe Montalto.Cyclooxygenases in hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(32):5113-5121. 被引量:25
  • 2林春艳,曹海燕,辛丽亚.血清中VEGF与AFP联合检测在原发性肝癌辅助诊断中的研究[J].哈尔滨医科大学学报,2006,40(6):483-485. 被引量:4
  • 3JEMAL A, BRAY F, CENTER M M, et al. Global cancer statis- tics[J]. CACancerJClin, 2011,61(2): 69-90.
  • 4PRINCIPE D R, DOLL J A, BAUER J, et al. TGF - β : duality of function between tumor prevention and carcinogenesis [ J ]. J Natl Cancer Inst, 2014, 106(2) : djt369.
  • 5MINCIONE G, DI MARCANTONIO M C, ARTESE L, et al. Loss of expression of TGF - hetal, ThetaR I , and ThetaR 1I correlates with differentiation in human oral squamous cell carcinomas [ J ]. Int J Oncol, 2008, 32(2) : 323 -331.
  • 6WOSZCZYK D, GOLA J, JURZAK M, et al. Expression of TGF beta1 genes and their receptor types I , I1, and 11I in low - and high -grade malignancy non - Hodgkin's lymphomas[ J]. Med Sci Monit, 2004, 10(1) : Cr33 -7.
  • 7HE L, ZHOU X, QU C, et al. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial - mesenchymal transition[J3. J Cell Mol Med, 2014, 18(1) : 49 -58.
  • 8HUANG F, CHEN Y G. Regulation of TGF -beta receptor activi- ty[J]. Cell Biosci, 2012, 2: 9.
  • 9HARPER J V, BROOKS G. The mammalian cell cycle: an over- view[ J]" Methods Mol Biol, 2005, 296:113 -153.
  • 10CASIMIRO M C, VELASCO VELAZQUEZ M, AGUIRRE AL- VARADO C, et al. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present [ J ]. Expert Opin Investig Drugs, 2014, 23(3) : 295 -304.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部